Homogeneous Assays for Cellular Protein Degradation Usingβ-Galactosidase Complementation: NF-κB/IκB Pathway Signaling

Publisher Website
Google Scholar
Abstract
Activation of cells by the tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) cytokines results in activation of the nuclear factor-κB (NF-κB) via proteasomal degradation of an associated IκB molecule. To monitor cellular IκB, the protein was recombinantly expressed as a fusion protein with a novel enzymatic tag, ProLabel (PL). ProLabel is a small 5.5-kDa sequence from the amino-terminal amino acids of β-galactosidase, possesses a simple ribbon structure, and can be fused to many proteins via the amino or carboxyl terminus. Expression of this construct allows quantitative detection of the recombinant protein in crude lysates by using a method based on β-galactosidase enzyme fragment complementation (EFC). Transient transfection of IκB-PL in HeLa cells generated an EFC signal that was highly correlated with a western analysis of the protein construct. ProLabel expressed alone in the cells did not show any EFC activity, due to rapid proteolytic degradation, indicating a very low background signal from the protein tag. TNF-α and IL-1 treatment induced a concentration-dependent degradation of IκB-PL, with potency values similar to those reported using other methods. IκBM-PL (mutant of IκB-PL), in contrast, did not undergo degradation for concentrations up to and including 10 ng/ml TNF-α or IL-1, demonstrating that degradation of IκB-PL was specific to the NF-κB pathway activation. TNF-α and IL-1 induced maximal IκB-PL degradation within 30 min of induction. This was reversed by several agents that ablate this pathway, including anti-TNF-α antibodies and the proteasome inhibitor, MG-132. The assay was amenable to HTS systems, with good precision and reproducibility. Z′ values and coefficients of variance for IκB-PL degradation were 0.6 and <9%, respectively.